FCGR2B and neoplasm: Importantly, this W104A mutation in the S2B sequence allowed conditional activation of 6G11 function in vitro by a tumor‐associated protease, as shown by Western blot analysis of the FcγRIIB phosphorylation state in target cells, without the need to artificially remove the cleaved‐off mask.